Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Sanofi Says Reversed Taxotere Win Resolvable Without New Trial

Feb. 25, 2022, 3:56 PM

Sanofi US Services Inc. asked a Fifth Circuit panel to revisit its decision ordering a new trial in a woman’s suit alleging a cancer drug caused permanent hair loss, saying it’s entitled to a win even without the expert testimony the court said was improperly admitted.

Barbara Earnest alleged Sanofi failed to warn that hair loss, a common side effect of chemotherapy, could be permanent in patients treated with Taxotere. In 2019, a jury in the U.S. District Court for the Eastern District of Lousiana rejected her arguments that Taxotere was responsible for her permanent hair loss.

Hers was the ...